The effect of metformin on blood pressure and metabolism in nondiabetic hypertensive patients

Journal of Internal Medicine

Volumn 242, Issue 5, 1997, Pages 407-412

  Snorgaard, O ^a   Kober L ^b   Carlsen, J ^c  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Medicon Clinical Research   (Denmark)

Author keywords

Ambulatory blood pressure; C peptide; Hypertension; Insulin; Metformin

Indexed keywords

C PEPTIDE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LACTIC ACID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; TRIACYLGLYCEROL;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MALE; METABOLISM; ORAL GLUCOSE TOLERANCE TEST; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE;

EID: 0030728375     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.00236.x     Document Type: Article

References (17)

1. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenale system. N Engl J Med 1996; 334: 374-81.
2. Dunn CJ, Peters DH, Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 1995; 49: 721-49.
3. Stumvoll M, Nurjahan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 550-54.
4. Carlsen SM, Rossvoll O, Bjerve KS, Følling I. Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease. J Intern Med 1996; 239: 227-33.
5. Hermann LS. Clinical pharmacology of biguanides. In: Kuhlmann J & Puls W, eds. Handbook of Experimental Phamacology, volume 119 (Oral antidiabetics). Heidelberg, Berlin, New York: Springer Verlag, 1996; 373-407.
6. Landin K, Tengborn L, Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J intern Med 1991; 229: 181-7.
7. Giugliano D, De Rosa N, Di Maro R, Marfella R, Acampora R, Buoninconti R, D'Onofrio F. Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women. Diabetes Care 1993; 16: 1387-90.
8. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994; 43: 647-54.
9. Landin K, Tengborn L, Smidt U. Metformin and metoprolol CR treatment in non-obese men. J Intern Med 1994; 235: 335-41.
10. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983; 29: 1075-80.
11. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977; 23: 882-4.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
13. Verma S, Bhanot S, McNeill JH. Metformin decreases plasma insulin levels and systolic blood pressure in spontaneously hypertensive rats. Am J Physiol 1994; 267: H1250-53.
14. Coats AJS, Radaelli A, Clark SJ, Conway J, Sleight P. The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens 1992; 10: 385-91.
15. Ogihara T, Rakugi H, Ikegami H, Mikami H, Masuo K. Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. Am J Hypertens 1995; 8: 316-20.
16. Iwamoto Y, Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T. Effect of combination therapy of troglitazone and sulphonylureas in patients with type 2 diabetes who were poorly controlled by sulphonylurea therapy alone. Diabetic Med 1996; 13: 365-70.
17. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994; 331: 1188-93.